Results 201 to 210 of about 4,942 (259)

Association of PCSK9 inhibitors versus statins with cancer incidence: a target trial emulation. [PDF]

Cardiooncology
Huang CH, Wang SI, Fan FS, Lu HJ, Wei JC.   +4 more
europepmc   +1 more source

Not only ISCHEMIA — report from AHA Scientific Sessions, Philadelphia, 16–18 November 2019 [PDF]

, 2020
Kasprzak, Jarosław D., Rechciński, Tomasz   +1 more
core   +1 more source

Genetic Pathogenesis of Abdominal Aortic Aneurysm and the Role of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9). [PDF]

Vasc Specialist Int
Choi JY, Gwon JG.
europepmc   +1 more source

A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300 mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects With Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

Novartis
openalex   +1 more source

Triple Non-Statin Therapy with Ezetimibe, Inclisiran, and Bempedoic Acid in Patients with Genetically Confirmed Statin-Induced Rhabdomyolysis: A Dual Case Report. [PDF]

Pharmaceuticals (Basel)
Dodulík J, Plášek J, Kacířová I, Uřinovská R, Vrtal J, Václavík J.   +5 more
europepmc   +1 more source

Translating the effect of dual lipid reduction with PCSK9 inhibitors on a mechanical vascular instrumental biomarker in familial hypercholesterolemia subjects. [PDF]

J Transl Med
Bosco G, Di Giacomo Barbagallo F, Di Marco M, Scilletta S, Miano N, Pistritto C, Tiralongo M, Di Stefano C, Pennisi G, De Francesco EM, Malaguarnera R, Di Pino A, Piro S, Scicali R.   +13 more
europepmc   +1 more source

Differential Protein Precipitation-Based GalNAc-siRNA Sample Preparation with LC/MS Method Development Workflow in Plasma. [PDF]

Anal Chem
Kim Y, Zhang TT, Sugimoto H, Qian MG, Dong L.   +4 more
europepmc   +1 more source

Small interfering RNA effect on lipoprotein(a): a systematic review. [PDF]

Egypt Heart J
Almaadawy O, Hesn MM, Elsalamony YA, Abobakr OA, Elshimy AH, Abulkhair KA, Negm MM, Shaban AY, Bene-Alhasan Y, Annie F, Belcher A, Elashery AR.   +11 more
europepmc   +1 more source

Expert Opinion on Targeted Lipid Control for Very-high-risk Indian Patients: Bridging the Gap in Real-world Practice. [PDF]

Eur Cardiol
Ray K, Kaul U, Rao S, Sinha N, Sahoo PK, Ponde CK, Mohan JC, Nair T, Mehta A, Gupta P, Sharma K.   +10 more
europepmc   +1 more source